Campbell & Co Investment Adviser’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-90,084
| Closed | -$601K | – | 1411 |
|
|
2025
Q1 | $601K | Buy |
90,084
+30,115
| +50% | +$201K | 0.05% | 605 |
|
|
2024
Q4 | $754K | Buy |
59,969
+33,718
| +128% | +$424K | 0.06% | 508 |
|
|
2024
Q3 | $485K | Buy |
26,251
+8,259
| +46% | +$153K | 0.04% | 733 |
|
|
2024
Q2 | $387K | Buy |
+17,992
| New | +$387K | 0.03% | 741 |
|
|
2022
Q2 | – | Sell |
-14,949
| Closed | -$237K | – | 873 |
|
|
2022
Q1 | $237K | Buy |
+14,949
| New | +$237K | 0.06% | 569 |
|
|
2021
Q4 | – | Sell |
-11,100
| Closed | -$332K | – | 778 |
|
|
2021
Q3 | $332K | Buy |
+11,100
| New | +$332K | 0.11% | 346 |
|